Clinical Trial: A Trial to Evaluate Safety, Tolerability, and Immune Responses of an Investigational Monovalent Chimpanzee Adenoviral Vectored Sudan Ebolavirus Vaccine in Healthy Adults

U.S., Feb. 1 -- ClinicalTrials.gov registry received information related to the study (NCT06803342) titled 'A Trial to Evaluate Safety, Tolerability, and Immune Responses of an Investigational Monovalent Chimpanzee Adenoviral Vectored Sudan Ebolavirus Vaccine in Healthy Adults' on Jan. 27.

Brief Summary: A Phase 2, Randomized, Double-blind, Placebo-Controlled Trial to Evaluate Safety, Tolerability, and Immune Responses of an Investigational Monovalent Chimpanzee Adenoviral Vectored Sudan Ebolavirus Vaccine in Healthy Adults

Study Start Date: June, 2025

Study Type: INTERVENTIONAL

Condition: Ebola Sudan Virus Disease

Intervention: BIOLOGICAL: cAD3-Sudan Vaccine

The recombinant chimpanzee adenovirus Type 3-vectored Sudan Ebolavirus vac...